| Product Name | MF | CAS | Details |
|---|
| HIV Protease Substrate VI | C40H66N12O11 | 130877-92-8 | Details |
| tert-Butyl N-[(3-cyanophenyl)methyl]carbamate | C13H16N2O2 | 916213-93-9 | Details |
| Pleconaril - Bio-X ? | C18H18F3N3O3 | 153168-05-9 | Details |
| H-KRQEILDLWVY-OH | Details |
| 3-Methyl-[1,2]oxazolo[5,4-c]pyridine | C7H6N2O | 83431-06-5 | Details |
| Elemene - mixture of isomers | C15H24 | 33880-83-0 | Details |
| Biotin caproic acid | C16H27N3O4S | 72040-64-3 | Details |
| 3,4-Dihydro-2H-pyrazino[1,2-a]indol-1-one | C11H10N2O | 152193-85-6 | Details |
| 2-Isopropylphenyboronic acid pinacol ester | C15H23BO2 | 852110-33-9 | Details |
| Pigment red 81 | C28H31N2O3.xUnspecified | 12224-98-5 | Details |
| 2-Chloro-N-[1-(2-methylphenyl)propan-2-yl]acetamide | C12H16ClNO | 1183650-81-8 | Details |
| 2-(1-Methyl-1H-imidazol-2-yl)pyridin-3-ol | C9H9N3O | 1551469-58-9 | Details |
| 2,3,5,6-Tetramethyl-N-(prop-2-en-1-yl)benzene-1-sulfonamide | C13H19NO2S | 731002-01-0 | Details |
| MSH6 Blocking Peptide | Details |
| DEAF1 antibody | Details |
| 3-Amino-estra-1,3,5(10)-trien-17β-ol | C18H25NO | 10427-24-4 | Details |
| Smpdl3a Blocking Peptide | Details |
| 3-(Morpholin-4-yl)pyridin-2-amine | C9H13N3O | 1036645-86-9 | Details |
| N~1~-(2,3-Dimethylphenyl)glycinamide hydrochloride | C10H15ClN2O | 1049751-82-7 | Details |
| {4-[(2-Fluorophenyl)methoxy]phenyl}methanamine | C14H14FNO | 849807-01-8 | Details |
| 3-Cyanophenylacetic acid | C9H7NO2 | 1878-71-3 | Details |
| MPP3 antibody | Details |
| Methyl 3-[2,2,2-trifluoro-N-(propan-2-yl)acetamido]propanoate | C9H14F3NO3 | 1443981-17-6 | Details |
| 1-[(4-Fluorophenyl)methyl-methylcarbamoyl]cyclopropane-1-carboxylic acid | C13H14FNO3 | 1457625-95-4 | Details |
| 2,2-Dimethylpent-4-enenitrile | C7H11N | 2978-30-5 | Details |
| SCFD1 antibody | Details |
| AS2717638 | C25H25N3O5 | 2148339-28-8 | Details |
| N-Des(4-Fluorophenyl)-N-(3-fluorophenyl) Ezetimibe | C24H21F2NO3 | 1700622-06-5 | Details |
| (3-(phenylmethoxy)(2-pyridyl))((4-(trifluoromethoxy)phenyl)sulfonyl)amine | C19H15F3N2O4S | 497060-26-1 | Details |
| Histone H3 (1-25), amide | C110H202N42O32 | 1373320-65-0 | Details |
| KLHL9 antibody | Details |
| H-FMYSDFHFI-OH | Details |
| N-(2,4-dichlorophenyl)-2-nitrilo-3-(2-pyridylamino)prop-2-enamide | C15H10Cl2N4O | 1025677-86-4 | Details |
| Streptomycin sulfate | C21H41N7O16S | 3810-74-0 | Details |
| Boc-Thr(Val-Fmoc)-OH | C29H36N2O8 | 887707-95-1 | Details |
| rac-(2R,3R)-3-(Aminomethyl)oxolane-2-carboxylic acid hydrochloride | 2138163-93-4 | Details |
| Pyrimidine-5-carboxamidine hydrochloride | C5H6N4 | 690619-43-3 | Details |
| Acetyl-GRP (20-26) (human, porcine, canine) trifluoroacetate salt | C41H57N13O8 | 121432-21-1 | Details |
| PTPN6 antibody | Details |
| 1-(2-(4-chlorophenylthio)propionyl)-4-phenylsemicarbazide | C16H16ClN3OS2 | 1024477-92-6 | Details |
| 2-Methylundecane | C12H26 | 7045-71-8 | Details |
| 2-((4-benzylmorpholin-2-yl)methyl)isoindoline-1,3-dione | C20H20N2O3 | 110859-48-8 | Details |
| Vu 590 dihydrochloride | C24H34Cl2N4O7 | 1783987-83-6 | Details |
| [Ser25]-PKC (19-36) Substrate | C93H159N35O25 | Details |
| 6-Chloro-4-methoxythieno[2,3-b]pyridine | C8H6ClNOS | 99429-84-2 | Details |
| Methyl 3,4-dimethylcinnamate | C12H14O2 | 86761-33-3 | Details |
| 2-(Pyridin-2-yl)morpholine | C9H12N2O | 1018656-53-5 | Details |
| alpha-D-Glucose-1-phosphate disodium salt hydrate | C6H11Na2O9P | 56401-20-8 | Details |
| 2-Methyl-5-[(methylamino)methyl]furan-3-carboxylic acid hydrochloride | C8H12ClNO3 | 1955530-63-8 | Details |
| 5-(1H-Imidazol-2-yl)-2-methylaniline | C10H11N3 | 1126367-12-1 | Details |
| 3,6-Diaminohexanoic acid dihydrochloride | 1071678-05-1 | Details |
| 5,5-Dimethyloxolane-3-sulfonamide | C6H13NO3S | 1935017-89-2 | Details |
| 7-Chloro-3-(propan-2-yl)-[1,2,4]triazolo[4,3-c]pyrimidine | C8H9ClN4 | 1094425-28-1 | Details |
| 6-Cyclobutylmorpholin-3-one | C8H13NO2 | 1857078-46-6 | Details |
| Ethyl a-D-fructofuranoside | C8H16O6 | 81024-99-9 | Details |
| 4-Chloro-3-{[2-(morpholin-4-yl)phenyl]sulfamoyl}benzoic acid | C17H17ClN2O5S | 380349-02-0 | Details |
| FSLLRY-NH2 | C39H60N10O8 | 245329-02-6 | Details |
| 2-{2-Oxa-6-azaspiro[3.3]heptan-6-yl}ethan-1-ol | C7H13NO2 | 26096-35-5 | Details |
| (E)-4-Propoxycinnamic acid | C12H14O3 | 151539-67-2 | Details |
| Hexahydropyrrolizin-1-one | C7H11NO | 14174-83-5 | Details |
| Methyl 2-amino-3-(3-fluorophenyl)propanoate hydrochloride | C10H13ClFNO2 | 64493-16-9 | Details |
| 2-tert-Butyl-5-nitrobenzoic acid | C11H13NO4 | 14034-90-3 | Details |
| Ethyl 1,4-dimethyl-1H-1,2,3-triazole-5-carboxylate | C7H11N3O2 | 1393561-26-6 | Details |
| Lithium 4-methyl-3-oxomorpholine-2-carboxylate | C6H10LiNO4 | 2031261-08-0 | Details |
| NBDHEX | C12H15N3O4S | 787634-60-0 | Details |
| 1,2-Dihydrospiro[indole-3,3'-pyrrolidine]-2-one hydrochloride | C11H13ClN2O | 1803592-37-1 | Details |
| 2-(Trifluoromethyl)bicyclo[2.2.1]heptane-2-carboxylic acid | C9H11F3O2 | 1896752-94-5 | Details |
| 2-Cyclopentyl-1-(1,4-diazepan-1-yl)ethan-1-one hydrochloride | C12H23ClN2O | 1148033-43-5 | Details |
| 2-[(2-Acetamidoethyl)amino]propanoic acid hydrochloride | C7H15ClN2O3 | 1485738-48-4 | Details |
| (5-Chloro-2,3-dihydro-1-benzofuran-7-yl)(cyclopropyl)methanol | C12H13ClO2 | 1566939-13-6 | Details |
| PGP9.5 antibody | Details |
| Collagenosis Antibody Positive Human Plasma | Details |
| 1,2,3,4-Tetra-O-acetyl-D-xylopyranose | C13H18O9 | 62446-93-9 | Details |
| (Methylamino)thiourea | C2H7N3S | 21185-13-7 | Details |
| 1,3-Dioxo-2-pyridin-3-ylmethyl-2,3-dihydro-1H-isoindole-5-carboxylic acid | C15H10N2O4 | 348125-25-7 | Details |
| tert-Butyl 4-(2-oxoimidazolidin-1-yl)piperidine-1-carboxylate | C13H23N3O3 | 902133-63-5 | Details |
| PUS10 antibody | Details |
| H-FTFSLDTSK-OH | Details |
| Methyl 2-(3-bromo-4-methylphenyl)acetate | C10H11BrO2 | 1261453-29-5 | Details |
| 4-(2-Fluoroethoxy)aniline | C8H10FNO | 1547-12-2 | Details |
| Kaempferol-3-glucoside-7-rhamnoside | C27H30O15 | 2392-95-2 | Details |
| OBOX6 Blocking Peptide | Details |
| Ethyl 2-[(1-ethoxyethylidene)amino]acetate | C8H15NO3 | 21164-33-0 | Details |
| HAPLN1 Blocking Peptide | Details |
| 4-[(2,4-Diaminopyrimidin-5-yl)methyl]-2-methoxyphenol hydrobromide | C12H15BrN4O2 | 122439-97-8 | Details |
| EIF3S12 antibody | Details |
| 5-Cyclopropoxy-2-methylpyridin-4-amine | C9H12N2O | 1243360-82-8 | Details |
| 3-Ethoxypyridine-2-sulfonamide | C7H10N2O3S | 1566861-15-1 | Details |
| 2-Chloro-N-(3-cyano-4,5-dimethylthien-2-yl)acetamide | C9H9ClN2OS | 124476-88-6 | Details |
| 5-(2,5-Dichlorophenyl)-1,2,4-triazin-3-amine | C9H6Cl2N4 | 886497-17-2 | Details |
| (2S,3S)-trans-3-Phenyl-2-oxiranylmethyl 4-nitrophenyl carbonate | C16H13NO6 | 147349-28-8 | Details |
| H-LQDAYGGWANR^-OH | Details |
| Genistein D4-7-O-glucoside | Details |
| 8-Fluoro-3,4-dihydro-1H-2-benzothiopyran-4-one | C9H7FOS | 186424-40-8 | Details |
| 6-Methoxy-2,3-dihydro-1H-indene-5-sulfonamide | C10H13NO3S | 88085-84-1 | Details |
| LIPI Blocking Peptide | Details |
| 4-(1H-1,2,3-Triazol-4-yl)benzoic acid | C9H7N3O2 | 1256164-21-2 | Details |
| 5-(Trifluoromethyl)-1,3,4-thiadiazol-2(3H)-one | C3HF3N2OS | 84352-75-0 | Details |
| 4-(4-Methylphenyl)-2-(1H-pyrrol-2-yl)-1,3-thiazole hydrobromide | C14H13BrN2S | 1909316-76-2 | Details |
| 1-(Thiophen-3-yl)-1,3-diazinane-2,4-dione | C8H8N2O2S | 1503951-18-5 | Details |
| Product Total： Product Page： | ||||
| 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 | ||||